These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 24462359

  • 1. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
    Zhang X, Li F, Guo S, Chen X, Wang X, Li J, Gan Y.
    Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
    [Abstract] [Full Text] [Related]

  • 2. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H.
    Mater Sci Eng C Mater Biol Appl; 2018 Mar 01; 84():108-117. PubMed ID: 29519418
    [Abstract] [Full Text] [Related]

  • 3. Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery system.
    Wang X, Teng Z, Wang H, Wang C, Liu Y, Tang Y, Wu J, Sun J, Wang H, Wang J, Lu G.
    Int J Clin Exp Pathol; 2014 Mar 01; 7(4):1337-47. PubMed ID: 24817930
    [Abstract] [Full Text] [Related]

  • 4. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
    He Q, Gao Y, Zhang L, Zhang Z, Gao F, Ji X, Li Y, Shi J.
    Biomaterials; 2011 Oct 01; 32(30):7711-20. PubMed ID: 21816467
    [Abstract] [Full Text] [Related]

  • 5. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
    Nakamura Y, Oka M, Soda H, Shiozawa K, Yoshikawa M, Itoh A, Ikegami Y, Tsurutani J, Nakatomi K, Kitazaki T, Doi S, Yoshida H, Kohno S.
    Cancer Res; 2005 Feb 15; 65(4):1541-6. PubMed ID: 15735043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Preliminary study on pH-sensitive lipid bilayer-coated mesoporous silica nanoparticles as a novel drug carrier for antitumor drug].
    Li FF, Zhang XX, Guo SY, Gan Y, Li J.
    Yao Xue Xue Bao; 2013 Feb 15; 48(2):291-7. PubMed ID: 23672029
    [Abstract] [Full Text] [Related]

  • 9. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.
    Ma B, He L, You Y, Mo J, Chen T.
    Drug Deliv; 2018 Nov 15; 25(1):293-306. PubMed ID: 29334793
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles.
    Pan L, Liu J, He Q, Wang L, Shi J.
    Biomaterials; 2013 Apr 15; 34(11):2719-30. PubMed ID: 23337327
    [Abstract] [Full Text] [Related]

  • 12. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
    Chen HH, Huang WC, Chiang WH, Liu TI, Shen MY, Hsu YH, Lin SC, Chiu HC.
    Int J Nanomedicine; 2015 Apr 15; 10():5035-48. PubMed ID: 26346762
    [Abstract] [Full Text] [Related]

  • 13. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y, Fu J, Wang T, Lu X.
    Acta Biomater; 2017 Mar 15; 51():471-478. PubMed ID: 28131940
    [Abstract] [Full Text] [Related]

  • 14. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J, Fang X, Hao J, Sha X.
    Biomaterials; 2015 Mar 15; 45():99-114. PubMed ID: 25662500
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.